ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 997

Feasibility and Influential Factors in Performing Self-Evaluation of DAS28 with Smart System of Disease Management (SSDM) By RA Patient in China

Mu Rong1, Fei Xiao2, Chun Li3, Jianlong Guan4, Yan Shen4, Dongbao Zhao5, Xia Xu6, Lindi Jiang7, Huiyong Chen7, Li Su8, Yuhua Jia2, Li Zhang2, Yuan Liu2 and Zhan-Guo Li3, 1Department of Rheumatology and Immunology, People's Hospital, Beijing University Medical School, Beijing, China, 2Gothic Internet Technology Corporation, Shanghai, China, 3Department of Rheumatology & Immunology, People's Hospital, Beijing University Medical School, Beijing, China, 4Huadong Hospital Affiliated to Fudan University, Shanghai, China, 5ShangHai ChangHai Hospital, ShangHai ChangHai Hospital, ShangHai, China, 6Department of Rheumatology and Immunology, Changhai Hospital,Second Military Medical University,, Shanghai, China, 7Zhongshan Hospital, Fudan University, Shanghai, China, 8Longhua Hospital Shanghai University of TCM, Shanghai, China

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, Education, patient, rheumatoid arthritis (RA) and self-management

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: ARHP I: Exemplary Abstracts

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Regular evaluations of rheumatoid arthritis (RA) disease activities with disease activity score in 28 joints (DAS28) are critical steps to reach the goal of “Treat to Target”. However, over-load of RA patients and short supply of rheumatologists in China made these steps impossible in the clinic. An option is to realize self-disease-evaluation by RA patient. Due to the smart phone being widely used in 66% of Chinese people, a user-friend platform of the Smart System of Disease Management (SSDM) is a potential resolution for regular evaluations of RA disease activities. SSDM includes applications of self-evaluation of DAS28, HAQ, and digital records of medication and lab test results. SSDM is developed in IOS, Android and Web format with patient and physician’s interfaces. After patient entries the data, it synchronizes with the interface of authorized doctor in real time mode.

To verify the feasibility and influential factors in performing self-evaluation on DAS28 with SSDM by RA patients.

Methods: From December 14, 2014 to February 2, 2015, two phases of studies were performed and total 103 patients enrolled, with 55 and 48 patients in each phase, respectively. All patients met the 1987 ACR criteria for diagnosis of RA. Ten rheumatologists and two nurses from five hospitals in Beijing and Shanghai participated in the study.

Education courses were held in hospitals. Patients were taught how to do self-evaluations on DAS28 and HAQ with SSDM. After practice and passing the exam, the self-evaluation of DAS28 was performed and data was recorded in SSDM. The same patient was evaluated by doctor or nurse simultaneously.

Statistical analysis was performed using SAS software, version 9.4. Intra-observer reliability of tender joint counts (TJCs) and swollen joint counts (SJCs) were expressed through the intra-class correlation coefficient (ICC).

Results: Among 103 RA patients, Mean age was 55.20 ± 13.26 (23 to 72) years, mean disease duration was 8.91 ± 8.25 (1 to 34) years.

As of December 31, 2014 for phase I, the ICCs of TJCs and DAS28 scores were 0.93 and 0.94, but the ICC of SJCs was 0.68. The analysis showed that the duration of disease was the only associate factor with significant difference (P<0.05). Stratified analysis showed that the result of SJCs matched between patients and health professionals was in the group with disease duration of 6.86 ± 5.78 years, but mismatched group was 14.18 ± 10.26 years in disease duration which group of patients under valuated their SJCs.

In Phase II of 48 patients, the education courses were more emphasized in identification of swollen joints. As a result, the ICCs of SJCs, TJCs and DAS28 were improved to 0.93, 0.93 and 0.92, respectively.

The average time for patients to do self-evaluation on a composite of DAS28 and HAQ with SSDM was 7.11 ± 5.21 (2-30) minutes, median time for 5 minutes; and the corresponding time for health professionals was 6.55 ± 4.26 (1-20) and 2 minutes, respectively.

Conclusion: Through improving education, RA patients in China can master SSDM and perform accurate self-evaluation on DAS28 and HAQ. SSDM may serve as a valuable platform for assisting rheumatologists in rationally managing RA patients in order to reach the goal of “Treat to Target”.


Disclosure: M. Rong, None; F. Xiao, None; C. Li, None; J. Guan, None; Y. Shen, None; D. Zhao, None; X. Xu, None; L. Jiang, None; H. Chen, None; L. Su, None; Y. Jia, None; L. Zhang, None; Y. Liu, None; Z. G. Li, None.

To cite this abstract in AMA style:

Rong M, Xiao F, Li C, Guan J, Shen Y, Zhao D, Xu X, Jiang L, Chen H, Su L, Jia Y, Zhang L, Liu Y, Li ZG. Feasibility and Influential Factors in Performing Self-Evaluation of DAS28 with Smart System of Disease Management (SSDM) By RA Patient in China [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/feasibility-and-influential-factors-in-performing-self-evaluation-of-das28-with-smart-system-of-disease-management-ssdm-by-ra-patient-in-china/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-and-influential-factors-in-performing-self-evaluation-of-das28-with-smart-system-of-disease-management-ssdm-by-ra-patient-in-china/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology